The HealthTech Signal
Charta Health logo

Charta Health

AI medical chart review for billing accuracy across providers and health plans.

Charta Health is known for aI medical chart review for billing accuracy across providers and health plans. It is at the Series B stage with $85M raised and sits in our Revenue Cycle & Payments category.

chartahealth.com

What they do

Charta Health announced a $55 million Series B led by Insight Partners on November 10, 2026, bringing total funding to $85 million. Madrona, Bain Capital Ventures, South Park Commons and QuantumLight participated. Charta reported tenfold revenue growth over the previous 12 months. Its Charta for Payers suite includes six products: retrospective HCC coding, AI-automated second-pass coding, a smart coding platform, prospective risk adjustment intelligence, HCC validation and audit workflow, and HEDIS and quality care gap detection. Charta for Providers reviews charts before claim submission with findings available for human review in the EHR. Justin Liu is CEO and co-founder; Scott Morris is CTO and co-founder.

Source announcement

People in this update

  • Justin LiuCEO and co-founderSource
  • Scott MorrisCTO and co-founderSource

The record

Vertical
Revenue Cycle & Payments
Sub-segment
AI medical chart review
Product type
Platform software
Stage
Series B
Headquarters
Not disclosed
Region
Founded
Not disclosed
Total funding
$85M raised

Notable investors: Insight Partners, Madrona, Bain Capital Ventures, South Park Commons, QuantumLight.

Also in Revenue Cycle & Payments

See the Revenue Cycle & Payments market map

More in Revenue Cycle & Payments: Revenue Cycle & Payments startups/HealthTech startup database

Related on The Signal

Keep exploring